A study on estrogen receptor, progesterone receptors, HER-2/NEU status in breast cancer cases attending to a tertiary care hospital of Andhra Pradesh by Prashanthi J & Ramaswamy Naik M
 
Asian Pac. J. Health Sci., 2015; 2[4S]:67-71                                        e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Prashanthi & Naik    ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2015; 2[4S]:67-71                                                        67 
www.apjhs.com       
 
A study on estrogen receptor, progesterone receptors, HER-2/NEU status in breast cancer 
cases attending to a tertiary care hospital of Andhra Pradesh 
Prashanthi J1, Ramaswamy Naik M2 
1Assisant Professor, Department of Radio therapy, 2Professor and Head of Department of General Surgery, 
Government Medical College and General Hospital, Anantapuramu, Andhra Pradesh, India 
 
ABSTRACT 
 
BACKGROUND: Breast cancer is one of the commonest form of cancer leading to considerable mortality and 
morbidity in developing countrylike India with age adjusted rate of 25.8 per 1,00,000 population.it is observed that 
expression of certain epidermal growth factor for certain receptors like Estrogen receptor(ER), Progesterone 
receptor(PR) and HER2/neu receptors are increased in certain malignancies, estimating which can help in 
preventive, promotive and therapeutic aspects of breast malignancy. AIM: the current retrospective study was 
undertaken to assess the ER, PR and HER – 2 / new states in breast carcinoma at Government Medical College and 
General hospital, Anantapuramu. An effort is made also to assess certain epidemiological factors associated with 
breast cancers.RESULTS: The current study indicated that mean age of presentation is 50. years. breast cancers are 
common in middle age group woman of rural areas who premenopausal and are have less than two children. The 
commonest histological type found is infiltrating ductal carcinoma(NOS) type. Hormone – expression in our study 
in low compared to western population but comparable with Indian studies. 
Keywords: Breast cancer, Estrogen Receptor(ER), HER2/neu receptor, Progesterone receptor(PR) 
Introduction  
Carcinoma of breast per say, one of the commonest 
neoplasm presenting to any oncology/ department in 
the country. Breast cancer is adjudged as the 
commonest form of female cancer in India with a age 
adjusted rate as high as 25.8 per 1,00,000. The 
mortality resulting in Indian women because of Breast 
Cancer is estimated to about 12.7 per 1,00,000 women 
[1].  
Breast cancer is supposed to be the commonest form of 
cancer among the women in the entire world and 
second commonest cancer after cervical cancer in 
Indian women. Breast cancer incidence is raising at an 
alarming rate in India and abroad in the last decade, 
increasing the burden of breast cancer deaths in lower 
socio-economic countries [2]. 
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High levels of expression of either the epidermal 
growth factor receptor or the receptor-like 
HER2/neu gene product p185HER2 have been 
observed in a variety of human malignancies including 
breast cancer [3]. Hormone receptor status (Estrogen 
receptor & Progesterone receptor) & HER2 /neu 
expression form a very important prognostic markers in 
Breast cancer. Receptor positive cases have better 
prognosis compared to receptor negative cases [4] 
Triple negative Breast Cancer has worst prognosis [5]. 
Metastasis to lymph nodes in a breast cancer case 
forms one of the important prognostic factors [6]. 
Estrogen receptor(ER) & Progesterone Receptor(PR) 
status increased with advancing age [7]. Further it is 
postulated from the studies that breast feeding has 
protective effect against hormone receptor negative 
breast cancer [8-9]. With the aforementioned 
background, the current study is under taken to asses 
the hormone receptor status in breast cancer patients 
attending to Government Medical College and General 
Hospital. 
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Materials and methods 
The Current a retrospective study was under taken after 
obtaining clearance from Institutional Ethics 
Committee at Cancer Unit, Department of 
Radiotherapy in association with Department of 
General Surgery, Government Medical College and 
General Hospital, Anantapuramu from February 2013 
to February 2015. The study included a total number of 
ninety-seven subjects surviving with unilateral breast 
cancer of which all were females. Patients with 
incomplete information were excluded.  
The data of patients is collected from patient records 
after obtaining consent with respect to patient age, 
tumor size, stage, estrogen and progesterone receptor 
status and HER 2/neu status was evaluated by 
immunohistochemistry. All the data is collected from 
the subjects in a pretested proforma and analyzed 
systematically by using appropriate statistical methods. 
 
Observations and Discussion 
Distributions of cases as per age of patients: It is 
evident from Table No.1 that most common age of 
presentation was in 45 to 55 decades of life and median 
age of presentation was 52.7 years (range 28 to 75 
years). 64.6 % of patients were post-menopausal. 
similar findings are noticed in a study conducted by 
Porter etal [10] and Leong etal [11]. From the data it is 
evident that the incidence is quite common in the early 
middle age when compared to extremes of age. The 
median age of presentation in our study was 52 years 
and peak prevalence was found in the 45 to 55 years 
age group. Median age at diagnosis of cancer breast in 
the US was 61 yrs. Breast cancer occurs a decade 
earlier in Indian population [12]. 
 
Table No.1: Distribution of cases as per age 
Age group Total(n) Percentage (%) 
25-35 7 7.21 
36-45 22 22.68 
46-55 32 32.98 
56-65 22 22.68 
66-75 13 13.40 
75-85 01 1.03 
Total 97 100 
Mean 50 
Median 52.7 
 
Distribution of Subjects as to place of residence 
(Table -2): It is observed from the study that 49 
subjects amounting to 51.44% are hailing from rural 
areas while 48.56%(48) subjects belong to urban areas. 
usually it is evident that the incidence used to be less is 
rural areas due to adherence to the rural life style [13]. 
However, it is observed in the trends that the incidence 
is comparatively more in the rural areas and this 
observation may be attributed to the reasons such as 
low educational status, lack of awareness regarding the 
disease, lack of medical facilities for diagnosis and due 
to life style modifications. similar findings are noticed 
in the studies conducted by other authors [14-15]. 
 
Table:2 Distribution of study subjects according to Place of residence 
Place of residence No of study subjects % 
Urban 48 48.56 
Rural 49 51.44 
Total 97 100 
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Breast Cancer and Socio-economic status (Table -
3): Findings of the current study indicates that the 
incidence of breast cancer is common in richer socio-
economic sections of the society as observed in 
65.44%(n=159) of cases in comparison to poorer 
section of society. This fact may be attributed to the 
dietary habits such as high fat diet, less house 
hold/physical activity and associated factors. similar 
findings are observed in a study conducted by [16]. 
Socio-economic status depicted in the table is based on 
the white card issued by Government of Andhra 
Pradesh to the below poverty line population. 
 
Table:3 Distribution of study subjects according to Socio-economic status 
Socio-economic status No of study subjects(n) Percentage(%)  
Upper and middle class 63 65.44  
Lower class 34 34.66  
Total 97 100  
 
Relation of breast cancer cases to menopause: It is 
evident from Table -4 that breast cancer is common in 
premenopausal women when compared to 
postmenopausal women amounting to 62.88% and 
38.22% respectively. It can be stated that breast cancer 
is common in menstruating women and further it is 
observed that the women with two or less that two 
children are at increased risk when compared to 
women having 3 or more children.  Similar findings are 
noticed in studies conducted elsewhere [17-18]. the 
exact reason for this is not known. 
Table:4 Distribution of study subjects according to status of Menopause 
Status of menopause No of study subjects(n) Percentage (%)  
Pre-menopausal 61 62.88  
Post-menopausal 36 38.22  
Total 97 100  
 
Distribution of cases asper histo-pathology of 
cancerous lesion: It can be inferred from Table-5 that 
Histopathology showed infiltrating ductal carcinoma 
(IDC not otherwise specified (NOS)) was the 
commonest variant comprising of 94.2 % of cases. 
Similar findings were noticed in study conducted by 
Victor J etal [19]. This finding will help to stratify the 
risk of cancers and aid to take preventive and 
promotive measures to reduce morbidity arising from 
breast cancers. Further it is observed in the study that 
most common pathological nodal stage was N1 
followed by N0 (graph-1). These results are comparable 
to a study conducted by Bartelink H etal [20]. Most 
common pathological T stage was T2 followed by T3, 
T4 and T1 . 14(14.3%) cases showed distant metastasis. 
 
Table:4 Distribution of study subjects according to histopathology 
Histopathology No of study subjects(n) Percentage (%) 
Infiltrating ductal carcinoma not otherwise specified(NOS)) 91 94.22 
Others  07 5.88 
Total 97 100 
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Graph-1 Nodal staging 
Distribution of cases as per Receptor status: It can 
be deduced from table-5 that 50.51 % of cases are ER 
positive. 49.48 % of cases are ER negative. 48.45 % of 
case are PR positive. 51.54% cases are PR negative. 
34.02 % of cases expressed HER -2 /neu receptor and 
65.97 % are HER- 2 /neu negative. Of these 26.8 % 
cases are triple negative. Hormone   receptor status is 
an important prognostic factor in breast cancer. Breast 
cancer patients that are ER and PR positive have lower 
rate of mortality compared to hormone receptor 
negative patients [21].  Our study showed that 50.5 % 
of cases had ER expression while 48.4 % expressed 
PR. This is lower compared to Western studies which 
have reported 73 % ER expression and 58 % PR 
expression [22]. but comparable to other Indian studies 
[23]. HER2 / neu positivity was present in 34.02 % of 
our cases. In western studies these values ranged from 
17 % to 27 % [24].  HER2 / neu positive cases respond 
to Tramstuzumab. 26.8 % of cases are triple negative in 
our study. These case of have poor prognosis 
Table-5: Distribution of Study Subjects as per Receptor status 
Type of receptor Positive Negative 
 No. of subjects(n) Percentage (%) No. of Subjects(n) Percentage (%) 
Estrogen Receptor(ER) 49 50.51 48 49.48 
Progesterone Receptor(PR) 47 48.45 50 51.54 
HER2/neu receptor 33 34.02 64 65.97 
Triple Negative 26(26.8%) 
 
Conclusion 
Hormone receptor positive status in breast cancers is 
low as observed in our study when compared to 
western population but however the status is 
comparable to other studies done over Indian 
population. HER- 2/ neu expression is higher in our 
study compared to western studies and triple negative 
cases are also high compared to western population. 
Further we would like to conclude that breast cancers 
are common in middle age group woman of rural areas 
who premenopausal and are have less than two 
children. The commonest histological type found is 
infiltrating ductal carcinoma (NOS) type. 
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